Solu-medrol and Dermal cyst - a phase IV clinical study of FDA data

Summary:

Dermal cyst is reported as a side effect among people who take Solu-medrol (methylprednisolone sodium succinate), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Zometa, and have Bone loss.

The phase IV clinical study analyzes which people have Dermal cyst when taking Solu-medrol. It is created by eHealthMe based on reports of 39,265 people who have side effects when taking Solu-medrol from the FDA, and is updated regularly.

What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is often used in multiple sclerosis. eHealthMe is studying from 39,410 Solu-medrol users. Check the latest studies of Solu-medrol.

What is Dermal cyst?

Dermal cyst is found to be associated with 537 drugs and 522 conditions by eHealthMe. Check the latest studies of Dermal cyst.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

39,265 people reported to have side effects when taking Solu-medrol.
Among them, 30 people (0.08%) have Dermal cyst.

Among these 30 people:

How long have people been on Solu-medrol when they have Dermal cyst? *

What is the gender of people who have Dermal cyst when taking Solu-medrol? *

female: 20 %
male: 80 %

What is the age of people who have Dermal cyst when taking Solu-medrol? *

What are other drugs people take besides Solu-medrol? *

What are other side effects people have besides Dermal cyst? *

Pain: 28 people, 93.33%
Atelectasis (partial or complete collapse of the lung): 25 people, 83.33%
High Blood Pressure: 25 people, 83.33%
Tricuspid Valve Incompetence (inefficient heart valve): 24 people, 80.00%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 24 people, 80.00%
Mitral Valve Incompetence (inefficient heart valve): 24 people, 80.00%
Stress And Anxiety: 24 people, 80.00%
Dyspnea (difficult or laboured breathing): 24 people, 80.00%
Pleural Effusion (water on the lungs): 24 people, 80.00%
Osteonecrosis Of Jaw (death of bone of jaw): 24 people, 80.00%

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 13 people, 43.33%
Bone Loss: 13 people, 43.33%
Osteoporosis (bones weak and more likely to break): 6 people, 20.00%
Broken Bone: 6 people, 20.00%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 13.33%
Weight Loss: 1 person, 3.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 3.33%
Pneumonia: 1 person, 3.33%
Pain: 1 person, 3.33%
Neuralgia (pain in one or more nerves): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Solu-medrol and have Dermal cyst?

- Check whether Dermal cyst is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Solu-medrol:

Solu-medrol (39,410 reports)

Dermal cyst treatments and more:

Dermal cyst (3,605 reports)

How severe was Dermal cyst and when was it recovered:

Dermal cyst in Solu-medrol

Expand to all the drugs that have ingredients of methylprednisolone sodium succinate:

Dermal cyst and drugs with ingredients of methylprednisolone sodium succinate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Solu-medrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermal cyst:

Dermal cyst (537 drugs)

Browse all the conditions that are associated with Dermal cyst:

Dermal cyst (522 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Solu-medrol) and Solu-medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.